Mitochondrial subhaplogroups and differential risk of stavudine-induced lipodystrophy in Malawian HIV/AIDS patients

Author： Kampira Elizabeth   Kumwenda Johnstone   Van Oosterhout Joep J   Dandara Collet  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.14, Iss.16, 2013-12, pp. : 1999-2004

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Lamivudine/stavudine/nevirapine: Stavudine-induced lactic acidosis: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1330, 2010-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Stavudine extended release (once-daily, Bristol-Myers Squibb) for the treatment of HIV/AIDS

By Mateo Ma Gracia   Gutierrez Ma del Mar   Vidal Francesc   Domingo Pere  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1055-1064

Informa Healthcare

Access to resources Recommend Favorite

Impact of Mitochondrial Toxicity of HIV-1 Antiretroviral Drugs on Lipodystrophy and Metabolic Dysregulation

By  

Current Pharmaceutical Design, Vol. 16, Iss. 30, 2010-10 ,pp. : 3339-3351

Bentham Science Publishers

Access to resources Recommend Favorite

Indirect Costs in Ambulatory Patients with HIV/AIDS in Spain: A Pilot Study

By Oliva J.   Roa C.  

PharmacoEconomics, Vol. 21, Iss. 15, 2003-01 ,pp. : 1113-1121

Adis International

Access to resources Recommend Favorite

Development of a patient satisfaction questionnaire for HIV/AIDS patients in Nigeria

By Njilele A.  

International Journal of Clinical Pharmacy, Vol. 34, Iss. 1, 2012-02 ,pp. : 98-104

Springer Publishing Company

Access to resources Recommend Favorite